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Background: Fragile X Syndrome (FXS) and its associated disorders are caused by the expansion of the CGG repeat in
the 5’ untranslated region of the fragile X mental retardation 1 (FMR1) gene, with disease classification based on the
number of CGG repeats. The mechanisms of repeat expansion are dependent on the presence of cis elements and the
absence of trans factors both of which are not mutually exclusive and contribute to repeat instability. Expansions
associated with trans factors are due to the haploinsuffient or reduced expression of several DNA repair/metabolizing
proteins. The reduction of expression in trans factors has been primarily conducted in animal models without substantial
examination of many of these expansion mechanisms and trans factors in humans.
Results: To understand the trans factors and pathways associated with trinucleotide repeat expansion we have analyzed
two microarray datasets which characterized the transcript expression in patients with FXS and in controls.
Conclusion: We observed significant down regulation of DNA damage/repair pathway transcripts. This observation was
consistent in both datasets, which used different populations. Within these datasets, several transcripts overlapped in the
direction of association and fold change. Further characterization of these genes will be critical to understand their role
in trinucleotide repeat instability in FXS.
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Fragile X Syndrome (FXS, OMIM 300624) is caused by a
mutation in fragile X mental retardation 1 (FMR1).
Prevalence estimates for FXS in the general Caucasian
population is ~1 out of 4000 males and ~1 out of 8000
females [1,2]. This prevalence rate has been subsequently
substantiated by other reports, thus the rate is generally
regarded as the prevalence rate in a randomly mating
population [3]. FXS is a spectrum disorder in which af-
fected individuals have IQs ranging from low or moder-
ate to high functioning [4,5]. In over 98% of patients,
FXS is caused by expansion of the CGG repeats in the 5’
untranslated region of FMR1 located adjacent to exon1
on the X chromosome [6,7]. The CGG repeat region can
be grouped into four general allelic forms, based on the
CGG repeat length and stability, during transmission
from parent to child. The allelic forms include common* Correspondence: peprahek@mail.nih.gov
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reproduction in any medium, provided the orvariants containing 6–40 repeats; intermediate variants,
sometimes termed gray zone alleles, containing 41–54
repeats; premutation variants containing 55–199 repeats;
and the full mutation variants, containing >200 repeats
[1]. When the expansion exceeds 200 CGG repeats (i.e.
full mutation), it causes methylation of the FMR1 regula-
tory region, which induces transcriptional silencing [8].
This CGG repeats are periodically interspersed with
AGG interruptions; interestingly the presence of these
AGG interruptions in the CGG repeat have been shown
to reduced the risk of transmission of a full mutation to
offspring [9]. The transmission of the FXS full muta-
tion is usually maternally derived because sperm from
males with a premutation or a full mutation only carry
premutation alleles; however one case of a premutation
male who transmitted a full mutation to his daughter is
reported in the literature [10].
Similar to other trinucleotide expansion disorders (e.g.,
myotonic dystrophy, Huntington disease, and some
spinocerebellar ataxias) FXS CGG repeat expansions are
locus specific; that is, genome-wide instability is not
observed. This suggests that the mechanism of repeatThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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DNA repair proteins or other trans acting factors, as
such factors typically lead to genome-wide instability
(e.g., several colorectal cancers and diseases [11]).
Other mechanisms have been proposed to produce tri-
nucleotide repeat expansions that do not require a muta-
tion phenotype [12]. One mechanism suggests the
alternation of the stoichiometric amount of protein
product needed to maintain genomic integrity could
underlie trinucleotide repeat expansions without the
mutation phenotype. For example, a reduction in the
stoichiometric ratio of enzymes critical for DNA repair/
replication leading to locus-specific expansions has been
investigated in animal models [13,14]. Haploinsufficiency
has mainly focused on the proteins in the ATM/ATR
pathway to understand the intergenerational expansions
of CGG repeats [13,14]. Reports have clearly demon-
strated that haploinsufficiency of ATR and ATM (kinases
that function in resolution of stalled replication forks
and in double strand breaks, respectively) leads to in-
creased intergenerational expansion of CGG repeats
with a maternal and paternal bias, respectively [13,14].
Corroborating evidence of haploinsufficient expression
of DNA repair/replication protein transcripts has not
been reported in humans. Recently, expression analysis
of transcripts has occurred in patients with FXS [15-18].
We used two datasets to determine if expression tran-
scripts of DNA repair/replication enzymes were signifi-
cantly altered in patients with FXS compared to controls.
We observed that within both datasets there was sig-
nificant down regulation of several enzymes with char-
acterized functions in DNA repair and replication. In
addition, both datasets also showed an overlap of several
proteins important in maintaining genomic integrity.
Methods
Genes in DNA repair/replication pathways were com-
piled from the REACTOME pathway database (www.
reactome.org). FXS expression array data were obtained
from two sources. First, microarray expression dataset
GSE7329 was downloaded from the National Center for
Biotechnology Information Gene Expression Omnibus
(www.ncbi.nlm.nih.gov/geo/) database [16]. In this dataset,
expression profiles of blood-derived lymphoblastoid cells
from males with autism due to a fragile X mutation
(FMR1-FM), or autism due to a 15q11-q13 duplication
(dup(15q)), or individuals without autism spectrum dis-
orders (i.e. controls), were studied using Agilent Whole
Human Genome Oligo Microarray G4112A. Probes cor-
responding to the compiled list of genes in DNA repair/
replication pathways were identified on the Agilent
Whole Human Genome Array. Log (base 10) transformed
expression values were extracted from the downloaded
GSE7329 dataset directly. Analysis of Variance (ANOVA),followed with specific contrast between FXS and control
groups, was conducted in Partek Genomics Suite 6.5
(Partek, Inc., St. Louis, Missouri, USA). Second, gene ex-
pression related to DNA repair/replication pathways were
also assessed using data from our collaborators. Recently,
Rosales-Reynoso and colleagues published a gene expres-
sion profiling study of the total peripheral blood from 10
male patients with FXS and 10 controls [15]. Two-color
Human Genome Microarray (MWG Biotech H10K_DB)
from the Physiology Laboratory of the Universidad
Nacional Autónoma de México (http://microarrays.
ifc.unam.mx) was used for this study. Target prepar-
ation, hybridization, and initial data collection were
performed according to the Physiology Laboratory’s
in-house protocol. Signal quantification and normalization
were determined using the Array-Pro Analyzer 4.0 soft-
ware for microarray images (Media Cybernetics, L.P.,
Silver Spring, MD). Details about the experiment
protocol have been described previously [15]. Probes
corresponding to the compiled list of genes in DNA
repair/replication pathways were extracted from the
dataset. One sample t-test was conducted for the Log
transformed expression intensity ratios between pairs
of patients with FXS and controls in Partek Genomics
Suite 6.5. False discovery rate control (FDR < 0.05)
was applied to indentify the differentially regulated
genes.
Results
Rosales-Reynoso and colleagues reported significant down
regulation of Rad9A transcript, a DNA repair/cell cycle
check point protein within the ATR/ATM DNA repair
pathway, and up regulation of MSH6 (DNA mismatch re-
pair binding protein) in patients with FXS [15]. A decrease
in Rad9A transcripts could significantly impair DNA
repair/replication pathway which could lead to repeat ex-
pansion. To further investigate the haploinsufficiency hy-
pothesis, we examined the microarray datasets looking
specifically at genes in DNA repair/replication pathways
according to the curated REACTOME pathway database
(www.reactome.org). A total of 312 genes involved in DNA
repair and replication were obtained from REACTOME.
Among them, 277 genes have corresponding probes (522
probes) covered by the Agilent Whole Human Genome
Array G4112A which was used in the GEO dataset. Ana-
lysis of Variance (ANOVA) shows that 97 genes (35.0%)
were differentially regulated between FXS samples and
controls. Interestingly, the majority of the 97 genes (63
genes, 64.9%) were significantly down regulated (p < 0.05).
After correction for multiple testing, 45 genes (46.4%)
passed the false discovery rate threshold (FDR < 0.05). The
majority of these genes (33 out of 45 genes, 73.3%) were
down regulated (Figure 1). Expression data for several tran-
scripts are shown in Figure 1, including down regulated
Figure 1 Cluster heatmap showing expression profiles of DNA repair/replication related genes in individuals with fragile X Syndrome (FX)
and control subjects (con). Individual transcripts are shown on the x-axis and individual subjects are shown on the y-axis. The gene expression
intensities are color-coded with red being high and blue being low, as indicated by the color scale to the right. Fifty-six transcripts from 45 genes were
used for an unsupervised Pearson cluster analysis. These 45 genes demonstrated differential regulation between patients with FXS and control subjects
according to ANOVA analysis with FDR < 0.05. Similarities between subjects or transcripts are represented by the distances between branches to the left
and on the top, respectively. The closer the branches, the more similar the expression profiles of the corresponding subjects/transcripts.
Table 1 DNA damage/repair genes which overlap in both











BRCA2 0.004 0.01 −1.17 down
CDKN1A 0.02 0.03 −1.11 down
ERCC1 0.0003 0.04 −1.06 down
FANCC 0.02 0.001 −1.08 down
NUP98 0.002 0.01 −1.10 down
PSMB1 0.02 0.02 −1.04 down
PSMD9 0.0004 0.03 −1.08 down
PSME2 0.0001 0.008 −1.07 down
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nucleotide expansion [12,13]. To corroborate these find-
ings, we used the dataset from a Mexican population with
FXS [15]. This dataset contained 175 unique genes repre-
sented on the arrays by 364 probes. Similar to the GEO
dataset, the majority of genes in the DNA repair/replica-
tion pathway were down regulated. 109 genes were differ-
entially regulated between patients with FXS and controls
(p < 0.05). 92 genes passed the false discovery rate thresh-
old (FDR < 0.05). Of the genes that passed the false discov-
ery rate threshold, 89 were down regulated with 60 genes
having greater than 1.5-fold changes. We compared the
overlap of genes between the two datasets and found that
16 genes were present within both datasets which had
similar fold change (Table 1).PSME3 0.0005 0.003 −1.10 down
RFC1 0.003 0.02 −1.06 down
BUB3 0.02 0.009 1.10 up
POLB 0.007 0.01 1.08 up
PPP2R5A 0.02 0.02 1.05 up
PSMD10 0.005 0.01 1.03 up
RAD17 0.01 0.01 1.05 up
RANBP2 0.03 0.05 1.04 upDiscussion
Taken together, these data suggest differential expression
of transcripts in the DNA repair/replication in patients
with FXS compared to controls. Within patients with
FXS there is considerable heterogeneity in the expres-
sion of many of the DNA repair/replication proteins
(Figure 2). This could suggest that differential expression

















Figure 2 Signal intensity Log ratios. Differential expression of Rad9A (black bars), ATM (white bars), and OGG1 (gray bars) in cell lines containing
FMR1 full mutation (FM) and controls. Rad9A and OGG1 showed decreased expression of transcript in FMR1-FM cell lines compared to controls. In
a few FMR1-FM cell lines we observed a significant decrease in ATM (GSM176575, GSM176586, and GSM176589); however, the expression of ATM
was not significantly different from FMR1-FM and controls.
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susceptible to gene specific repeat expansions [19]. The
down regulated transcripts could also suggest that there
are several different pathways or combinations of down
regulated transcripts which could lead to repeat expan-
sion. The outcome of CGG expansion could occur
through different mechanisms within individuals as sug-
gested by animal models [13]. In fact, it is suggested that
females transmit large expansions which appear to be re-
pair dependent whereas males selectively delete large ex-
pansion and transmit small expansions which are
replication dependent [12]. This observation is supported
by haploinsufficient animal models [12,13]. Based on ani-
mal models and human data, we would suggest first char-
acterizing the CGG expansion within the mother [if
possible], with subsequent analysis in offspring by stratifi-
cation of family members with premutations or FXS based
on gender (e.g. paternal or maternal origin). In essence this
method, previously used by Nolin and colleagues would
allow for multi-generational characterization of the repair/
replication pathways essential for expansion [19].
Transcript expression data may not have a linear asso-
ciation with translation; subsequent in vitro follow-up is
needed to determine whether differential expression of
transcripts in the DNA repair/replication pathway corre-
sponds to alteration of protein levels in these enzymes.
Further investigations are needed to provide modelswhich couple decreased expression of DNA repair/repli-
cation enzymes with the mechanism of trinucleotide
repeat expansion in patients with FXS. Other evidence
from mouse models also shows a maternal and paternal
bias in the inheritance of expanded repeats based on
specific DNA replication/repair enzyme [12,13]. In
addition, familial studies of intergeneration expansion
have indicated evidence of different expansion rates [18].
This suggests that characterizing the mode of inherit-
ance of the CGG expansion (i.e., whether primarily ma-
ternal or paternal) would be significant in understanding
the inheritance. In effect, the mode of inheritance would
provide significant data leading to an understanding of
the enzymes which are significantly associated with ex-
pansion pathways.
Currently, only around 16 genes were found to be differ-
entially regulated with the direction of association similar
in both datasets. The limited number of genes found
through this analysis is due to the fact that two different
microarray experiments did not have a large number of
overlapping genes for the DNA damage/repair pathway
from REACTOME. We found that the degree of overlap
between both datasets was around 50%. However, within
this limited amount of data we found significant associa-
tions which we hope can be replicated by others. Overall,
these findings indicate that the DNA damage/repair path-
ways could significantly contribute to repeat instability.
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disorders suggests that many of these expansions arise
from several different mechanisms [12]. A second level of
complexity would also suggest that the DNA repair/repli-
cation mechanisms could have considerable cross talk [12].
Understanding the mechanism of trinucleotide repeat ex-
pansion in FXS would be beneficial to understanding other
trinucleotide repeat expansion disorders. Finally, the evolu-
tionary significance of loci-specific repeat expansion disor-
ders should not be understated. Evidence from this field
could engender greater understanding of the evolution of
the human genome and a greater understanding of how
genome fidelity is maintained.
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